Phase 2B study of tenecteplase (TNK) in acute ischemic stroke (TNK-S2B).
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2015
At a glance
- Drugs Tenecteplase (Primary) ; Alteplase
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- Acronyms TNK-S2B
- 26 Feb 2010 Results were presented at the 35th International Stroke Conference.
- 25 Feb 2010 Status changed from active, no longer recruiting to discontinued, as reported in Stroke.
- 25 Feb 2010 Results published in Stroke.